This organization files Form 990, which has no section for application policy. Its filings cannot say either way.
The latest filing we hold carries no statement about applications. That is not the same as closed: public-charity Form 990s have no field for it, and many foundations leave the section blank.
Grants paid by year
Total assets by year
Where the money went · FY2024
Form 990 splits expenses into program services, management and fundraising. The split is self-reported, and a grantmaker, a research institute and a direct-service nonprofit book the same work differently. A line the return does not carry reads "not available"; it is never counted as zero.
| Year | Form | Revenue | Expenses | Grants paid | Assets | Net assets |
|---|---|---|---|---|---|---|
| FY2024 | 990 | $66,947,169 | $54,471,034 | $29,715,699 | $223,870,654 | $185,438,438 |
| FY2023 | 990 | $23,662,636 | $42,903,351 | $14,807,382 | $255,027,743 | $202,213,973 |
| FY2022 | 990 | $32,769,137 | $62,241,652 | $18,087,363 | $307,154,607 | $249,519,391 |
| FY2021 | 990 | $170,996,190 | $52,643,221 | $9,050,381 | $380,437,987 | $327,532,401 |
| FY2020 | 990 | $66,027,113 | $69,855,756 | $26,340,166 | $152,630,223 | $144,770,423 |
Figures are as reported on the e-filed return, with no restatement. Fiscal years are the funder's own tax year, labelled by the calendar year the period ends in. A blank line means the return does not carry that figure; a real zero shows as $0. When an amended return replaces an original, every figure here uses the amended return. The original is not shown. Giving is what the funder actually paid out toward its charitable purpose in the year (qualifying distributions on Form 990-PF, charitable disbursements otherwise). Assets are what it holds; giving is what moves.
Recipient focus areas
Where recipients are
Based on the 90% of grant rows we could match to an organization record. The rest stay as reported. The IRS assigns the NTEE category when it grants exemption. It often reflects the original filing, not today's giving.
| Recipient | Purpose | Amount | Year | Source |
|---|---|---|---|---|
| REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISAN FRANCISCO, CA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $614,626 | 2023 | |
Recipients are shown as the funder wrote them on the return. A recipient with a link was matched to an organization record; the rest stay as reported and are never guessed.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| John Connolly Phd | CHIEF SCIENTIFIC OFFICER | 40.0 | $855,710 |
| Kevin Marks | CHIEF LEGAL OFFICER | 40.0 | $840,863 |
| Ute Dugan Md | CHIEF MED. OFFICER THRU 6/24 | 20.0 | $715,023 |
| Tarak Mody | CHIEF BUSINESS OFFICER |
From the officer list on the latest e-filed return. Compensation is as reported there; a blank means the return carries no figure.
| REGENTS OF UNIVERSITY OF CALIFORNIA SAN FRANCISCOSAN FRANCISCO, CA |
| SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| $574,028 |
| 2021 |
| UNIVERSITY OF CALIFORNIA LOS ANGELESLOS ANGELES, CA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $572,590 | 2021 |
| STANFORD UNIVERSITYPALO ALTO, CA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $556,995 | 2022 |
| ICAHN SCHOOL OF MEDICINENEW YORK, NY | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $551,172 | 2022 |
| INSTITUTE FOR SYSTEMS BIOLOGYRENTON, WA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $547,924 | 2022 |
| FHCRC - HUTCHINSONSEATTLE, WA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $528,249 | 2023 |
| CLINTON HEALTH ACCESS INITIATIVE INCBOSTON, MA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $500,000 | 2020 |
| WEILL CORNELL MEDICINENEW YORK, NY | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $495,462 | 2021 |
| INSTITUTE FOR SYSTEMS BIOLOGYRENTON, WA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $441,957 | 2020 |
| INSTITUTE FOR SYSTEMS BIOLOGYRENTON, WA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $441,957 | 2021 |
| UNIVERSITY OF PENNSYLVANIAPHILADELPHIA, PA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $441,669 | 2022 |
| FHCRC - HUTCHINSONSEATTLE, WA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $420,457 | 2022 |
| MEMORIAL SLOAN KETTERING CANCER CENTERNEW YORK, NY | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $399,355 | 2022 |
| CLINTON HEALTH ACCESS INITIATIVE INCBOSTON, MA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $380,000 | 2021 |
| THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTERHOUSTON, TX | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $377,267 | 2024 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTERHOUSTON, TX | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $376,120 | 2020 |
| CHILDREN'S HOSPITAL OF PHILADELPHIAPHILADELPHIA, PA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $360,000 | 2022 |
| CHILDREN'S HOSPITAL OF PHILADELPHIAPHILADELPHIA, PA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $360,000 | 2023 |
| BECKMAN RESEARCH INSTITUTE OF CITY OF HOPEDUARTE, CA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $333,333 | 2024 |
| BECKMAN RESEARCH INSTITUTE OF CITY OF HOPEDUARTE, CA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $333,333 | 2023 |
| FHCRC - HUTCHINSONSEATTLE, WA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $325,387 | 2021 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIALOS ANGELES, CA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $304,336 | 2023 |
| MEMORIAL SLOAN KETTERING CANCER CENTERNEW YORK, NY | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $278,726 | 2023 |
| BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPEDUARTE, CA | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY | $265,883 | 2021 |
| 40.0 |
| $632,310 |
| Shane Corcoran | SENIOR VP, STRAT. OPS. & COMMS | 40.0 | $669,429 |
| Sara Coblin | SR VP FINANCE & ADMIN. | 40.0 | $564,812 |
| Marko Spasic | SR MEDICAL DIR, HEAD OF MED | 40.0 | $418,090 |
| Christen Dipetrillo | HEAD OF INTELLECTUAL PROPERTY | 40.0 | $354,287 |
| Sean N Parker | CHAIR OF THE BOARD & DIRECTOR | 5.0 | $0 |
| Michael Polansky | EXECUTIVE VP & DIRECTOR | 5.0 | $0 |
| Tom Van Loben Sels | TREASURER & DIRECTOR | 1.0 | $0 |
| Jeffrey A Bluestone Phd | VICE CHAIR & DIRECTOR | 1.0 | $0 |
| Tony Coles Md | DIRECTOR | 1.0 | $0 |
| Eric Esrailian Md Mph | DIRECTOR | 1.0 | $0 |
| Scott Gottlieb Md | DIRECTOR | 1.0 | $0 |
| Ben Horowitz | DIRECTOR | 1.0 | $0 |
| Jeff Huber | DIRECTOR | 1.0 | $0 |
| Bob Hugin | DIRECTOR | 1.0 | $0 |
| Reed Jobs | DIRECTOR | 1.0 | $0 |
| Bob Nelsen | DIRECTOR | 1.0 | $0 |
| Bruce Parker Phd | DIRECTOR | 1.0 | $0 |
| Bob Pittman | DIRECTOR | 1.0 | $0 |
| Ramy Ibrahim Md | DIRECTOR | 1.0 | $0 |
| Margo Georgiadis | DIRECTOR | 1.0 | $0 |
| Susan Dawson | SECRETARY | 5.0 | $0 |
Nearest by size, location and giving pattern in the database. Geography weighs heavily. Treat it as a starting list, not a ranking of fit.
Form 990 · FY2023 · period ending Dec 31, 2023IRS bulk XML
Filing id 202442149349301434
Form 990 · FY2022 · period ending Dec 31, 2022
Filing id 202303189349306385
Form 990 · FY2021 · period ending Dec 31, 2021
Filing id 202213149349305531
Form 990 · FY2020 · period ending Dec 31, 2020
Filing id 202103169349307275
Form 990 · FY2019 · period ending Dec 31, 2019
Filing id 202043219349313849
Form 990 · FY2018 · period ending Dec 31, 2018
Filing id 201903179349305225
Form 990 · FY2017 · period ending Dec 31, 2017
Filing id 201813199349309596
Form 990 · FY2016 · period ending Dec 31, 2016
Filing id 201733199349313948
Form 990 · FY2015 · period ending Dec 31, 2015
Filing id 201613199349305716
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.